Apyx Medical Corporation reported a 32.4% increase in total revenue to $12.5 million for Q1 2026, driven by a 36% rise in its Surgical Aesthetics segment, including strong sales of the AYON Body Contouring System and Renuvion products internationally. The company narrowed its net loss to $2.1 million from $4.2 million a year earlier and improved its adjusted EBITDA loss to $0.3 million from $2.4 million. Encouraged by strong domestic and international demand, especially in South Korea, Apyx raised its full-year 2026 revenue guidance to $59.0-$60.0 million, up from prior estimates. Management expects continued growth in surgical aesthetics sales and plans to maintain operating expenses below $45 million for the year.
Sodexo has secured a major global contract to provide catering services across more than 130 Meta sites in over 30 countries. This large-scale partnership includes diverse locations such as headquarters, campuses, data centers, and conference centers...
Ethereum (ETH) surged past the $1,894.89 resistance level, accelerating its recovery toward the $1,940–$1,950 zone after days of consolidation. This breakout was supported by lower-than-expected U.S. inflation data, which boosted risk appetite and bu...
Allied Critical Metals announced positive assay results from its 2026 drilling campaign at the Santa Helena Breccia, part of the Borralha Tungsten Project in Portugal. The first drill hole confirmed broad zones of high-grade tungsten mineralization, ...
Ethereum's price rose about 11% over the past week to around $1,920, outperforming major cryptocurrencies like Bitcoin and Solana. This rally is fueled by $96 million inflows into U.S. spot Ether ETFs early in the week, with BlackRock's ETHA product ...
The XRP Ledger has surpassed 8 million activated accounts, marking steady growth since March 2026. However, daily active addresses have declined to a 2026 low of 25,350, indicating less frequent user engagement despite overall adoption. XRP's price f...
